United Kingdom · Question · Written question
UIN 76045
Cancer: Screening
Introduced
17 July 2020
Last action
25 August 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
25 August 2020
Summary
To ask the Secretary of State for Health and Social Care, what progress he has made in providing genomic testing for cancer patients who could benefit from treatment with histology independent therapies.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 July 2020
Written question
To ask the Secretary of State for Health and Social Care, what progress he has made in providing genomic testing for cancer patients who could benefit from treatment with histology independent therapies.
Source: Commons
25 August 2020
Answer
The first candidate histology independent therapy, larotrectinib, for treating advanced solid tumours with NTRK gene fusions has been approved by the National Institute for Health and Care Excellence (NICE) through the Cancer Drugs Fund, and final apprais...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-07-17/76045
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1225933
- uk · wq-1225933 · source updated 25 August 2020